Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombosis 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Metabolic Diseases 1Hematologic Neoplasms 1Catheter-Related Infections 1Bacteremia 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Methotrexate 2Busulfan 2Alemtuzumab 2AP 1903 reagent 2visilizumab 1thymoglobulin 1fludarabine 1Transplantation 1Teriparatide 1Saline Solution 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Parathyroid Hormone 1Melphalan 1Heparin 1Fluorescent Antibody Technique 1Ficusin 1Etoposide 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Clofarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anemia, Aplastic × Heparin × Clear all
NCT01343680 2012-05-30

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

Alberta Children's Hospital

Phase 3 Terminated
2 enrolled
Classical hematology

Anemia, Aplastic, Metabolic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡